Zomedica Corp. (ZOM) is veterinary wellness and health-based company. It offers diagnostics and treatments for pets by fixing their unmet medical needs. The company’s product line includes novel diagnostics and devices, which are intended to improve the health of patients.
The price of ZOM stock during the regular trading on February 17, 2022, was $0.40 with a gain of 5.26%. At last check in the premarket on February 18, 2022, the stock was further up by 7.17%.
ZOM: Events and Happenings
ZOM updated about its Executive management’s participation at the following events.
- Midwest Veterinary Conference held on February 17-19, 2022.
- Music City Veterinary Conference being held on February 18-20, 2022, and
- Q4 Earnings Release Conference is being held on February 25, 2022.
On February 15, 2022, ZOM updated that the Company’s sales organization is now led by Adrian Lock. He was Vice President and General Manager of the company and will lead sales management and professional service veterinarians. On January 27, 2022, ZOM provided an update on its business and marketing activities in Q1 2022. On December 15, 2021, ZOM announced its Executive management’s presence at the Virtual H.C. Wainwright BioConnect 2022 Conference held on 10-13, 2022.
ZOM: Key Financials
On November 12, 2021, ZOM released its financial results for the third fiscal quarter 2021 ended September 30, 2021. Some of the key updates are mentioned below.
Revenue
Net revenue in Q3 2021 was $22.5 thousand compared to no revenue in the same quarter of 2020. The company reported an increase in its revenue over the year.
EPS
Basic and diluted net loss per share in Q3 2021 was $6.34 million or $0.01 against $4.97 million or $0.01 in the same quarter of 2020. The net loss of the company increased over the yearly period.
On October 01, 2021, ZOM was informed about the acquisition of Pulse Veterinary Technologies for $70.9 million. Pulsevet is a leading electro-hydraulic shock wave technology for the treatment of a wide range of veterinary patients.
Conclusion
ZOM stock down-performed by 81% in the past year as the economic turmoil surrounded the international businesses due to pandemics. The current stock market gain by the company is likely the result of its announcement related to attendance of veterinary conferences and earnings release calls.
